FDA Approves First Systemic Treatment Olumiant (Baricitinib) for Alopecia Areata
Summary : The U.S. Food and Drug Administration approved Olumiant (baricitinib) oral tablets to treat adult patients with severe alopecia areata, a…
Summary : The U.S. Food and Drug Administration approved Olumiant (baricitinib) oral tablets to treat adult patients with severe alopecia areata, a…
Executive Summary The pharma also warns that an FDA complete response letter could be coming for its supplemental NDA to add atopic…